BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
To create leading company developing medicines targeting metalloenzymes
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
The company is one of the most profitable companies manufacturing speciality chemicals in India
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Subscribe To Our Newsletter & Stay Updated
